The androgen receptor and clinical challenges
This report is based on a seminar held during the 10th Annual Meeting of the British Uro‐oncology Group in London, 13‐14 September 2013. The seminar focused on all aspects of the role of the androgen receptor in prostate cancer, from an overview of the molecular mechanisms and underlying pathways to the development of therapeutic agents designed to inhibit the androgen receptor. Copyright © 2014 John Wiley & Sons
Source: Trends in Urology, Gynaecology and Sexual Health - Category: OBGYN Authors: Heather A. Payne, Michiel Sedelaar, Rob Jones Tags: Conference Report Source Type: research
More News: Cancer | Cancer & Oncology | Conferences | OBGYN | Prostate Cancer | Urology & Nephrology